Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
RESEARCH TOOLSreports
4D Molecular Therapeutics (FDMT) Stock Price & Analysis
168 Followers
FDMT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.44 - $36.25
Previous Close$26.35
Volume401.32K
Average Volume (3M)1.22M
Market Cap
$1.31B
Enterprise Value$1.04B
Total Cash (Recent Filing)$288.23M
Total Debt (Recent Filing)$14.67M
Price to Earnings (P/E)-9.6
Beta1.76
Next Earnings
May 09, 2024EPS Estimate
-$0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.73
Shares Outstanding49,778,127
10 Day Avg. Volume742,385
30 Day Avg. Volume1,220,150
Standard Deviation0.35
R-Squared0.16
Alpha0.00342
Financial Highlights & Ratios
Price to Book (P/B)4.26
Price to Sales (P/S)63.30
Price to Cash Flow (P/CF)-13.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue50.09
Enterprise Value/Gross Profit50.09
Enterprise Value/Ebitda-11.69
Forecast
1Y Price Target
$48.88Price Target Upside85.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
4D Molecular Therapeutics News
Ownership Overview
14.85% Insiders
9.94% Mutual Funds
12.67% Other Institutional Investors
62.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FDMT FAQ
What was 4D Molecular Therapeutics’s price range in the past 12 months?
4D Molecular Therapeutics lowest stock price was $9.44 and its highest was $36.25 in the past 12 months.
What is 4D Molecular Therapeutics’s market cap?
Currently, no data Available
When is 4D Molecular Therapeutics’s upcoming earnings report date?
4D Molecular Therapeutics’s upcoming earnings report date is May 09, 2024 which is in 21 days.
How were 4D Molecular Therapeutics’s earnings last quarter?
4D Molecular Therapeutics released its earnings results on Feb 29, 2024. The company reported -$0.69 earnings per share for the quarter, beating the consensus estimate of -$0.726 by $0.036.
Is 4D Molecular Therapeutics overvalued?
According to Wall Street analysts 4D Molecular Therapeutics’s price is currently Undervalued.
Does 4D Molecular Therapeutics pay dividends?
4D Molecular Therapeutics does not currently pay dividends.
What is 4D Molecular Therapeutics’s EPS estimate?
4D Molecular Therapeutics’s EPS estimate is -$0.75.
How many shares outstanding does 4D Molecular Therapeutics have?
4D Molecular Therapeutics has 49,778,126 shares outstanding.
What happened to 4D Molecular Therapeutics’s price movement after its last earnings report?
4D Molecular Therapeutics reported an EPS of -$0.69 in its last earnings report, beating expectations of -$0.726. Following the earnings report the stock price went up 4.818%.
Which hedge fund is a major shareholder of 4D Molecular Therapeutics?
Among the largest hedge funds holding 4D Molecular Therapeutics’s share is Viking Global Investors LP. It holds 4D Molecular Therapeutics’s shares valued at 97M.
---
4D Molecular Therapeutics Stock Smart Score
Company Description
4D Molecular Therapeutics
4D Molecular Therapeutics Inc is a development stage precision gene therapy company. It engages in developing a broad pipeline of transformative gene therapy product candidates designed to treat patients suffering from lysosomal storage diseases, lung diseases, muscular dystrophies, and ophthalmic diseases. The AAV vectors are designed to provide targeted delivery by routine clinical routes, efficient transduction, reduced immunogenicity and resistance to pre-existing antibodies which enable to develop gene therapies.
---
FDMT Stock 12 Months Forecast
Average Price Target
$48.88
▲(85.50% Upside)
Technical Analysis
Best Analysts Covering FDMT
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+39.58%
reiterated a buy rating 2 months ago
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +39.58% per trade.
---